Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Lung Neoplasms 6Neoplasms 4Colonic Neoplasms 3Prostatic Neoplasms 2Patient Satisfaction 2Ovarian Neoplasms 2Breast Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Tuberculosis, Pulmonary 1Thoracic Diseases 1Supratentorial Neoplasms 1Stomach Ulcer 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Polyps 1Pituitary Neoplasms 1Pain, Postoperative 1Pain 1Overweight 1Obesity 1Neurofibromatoses 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Mouth Neoplasms 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hypoxia 1

Interventions

Dexmedetomidine 3Cabergoline 3pegvisomant 1pasireotide 1lanreotide 1Trimethoprim 1Sulfamethoxazole 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Propofol 1Prednisone 1Octreotide 1Ibuprofen 1Hydrocortisone 1Hormone Replacement Therapy 1Cefdinir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pituitary Neoplasms × Propofol × Clear all
NCT05822817 2025-06-08

Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery

Peking Union Medical College Hospital

Phase 4 Completed
252 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡